DNLI

Denali Therapeutics Inc. [DNLI] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

DNLI Stock Summary

Top DNLI Correlated Resources

DNLI


Top 10 Correlated ETFs

DNLI


Top 10 Correlated Stocks

DNLI


In the News

DNLI Financial details

Company Rating
-
Market Cap
2.54B
Income
-145.22M
Revenue
330.53M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
445
Optionable
No
Shortable
Yes
Earnings
06 May 2024
P/E
-21.84
Forward P/E
-
PEG
3.64
P/S
8
P/B
2.43
P/C
-
P/FCF
-7.85
Quick Ratio
15.58
Current Ratio
16.06
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.04
EPS next Y
-
EPS next Q
-
EPS this Y
-59.23%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-12.53%
Revenue last 5Y
65.43%
Revenue Q/Q
-
EPS Q/Q
19.44%
-
-
-
-
SMA20
-17.65%
SMA50
-33.33%
SMA100
-50%
Inst Own
-
Inst Trans
-
ROA
-10%
ROE
-12%
ROC
-0.15%
Gross Margin
100%
Oper. Margin
-50%
Profit Margin
-37%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
15.45-33.31
52W High
-63.24%
52W Low
-19.13%
RSI
29
Rel Volume
1.76
Avg Volume
1.18M
Volume
2.09M
Perf Week
-14.09%
Perf Month
-43.82%
Perf Quarter
-54.26%
Perf Half Y
-58.78%
-
-
-
-
Beta
1.331
-
-
Volatility
0.84%, 2.03%
Prev Close
-10.78%
Price
12.13
Change
-14.85%

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap